Medications

FDA: Zofran 32-mg dose pulled from market

(HealthDay)—The 32-mg, single intravenous dose of Zofran (ondansetron), an anti-nausea drug, is being removed from the market due to its potential to cause serious, even fatal, cardiac damage, according to a Drug Safety ...

Cardiology

Simplifying heart surgery with stretchable electronics devices

(Medical Xpress)—Researchers at the McCormick School of Engineering are part of a team that has used stretchable electronics to create a multipurpose medical catheter that can both monitor heart functions and perform corrections ...

page 10 from 18